FA
FTAI Aviation Ltd. (FTAI)·Q1 2025 Earnings Summary
Executive Summary
- Q1 2025 delivered record Adjusted EBITDA of $268.6M on $502.1M revenue, with Aerospace Products EBITDA of $130.9M at a 36% margin; the quarter continued strong momentum with a module production ramp and >100 Module Factory customers .
- Results vs consensus: revenue missed by ~11.6% ($502.1M vs $567.7M est.), but normalized “Primary EPS” beat ($1.02 vs $0.95 est.); GAAP diluted EPS was $0.87 (beat/miss metrics per S&P Global consensus) . Values with asterisks retrieved from S&P Global.
- Guidance reiterated: 2025 segment Adjusted EBITDA of $1.10–$1.15B (Leasing ~$500M; Aerospace Products $600–$650M) and 2026 raised previously to ~$1.4B; H1 2025 adjusted FCF guided to $300–$350M; dividend maintained at $0.30 .
- Catalysts: SCI scaling to >$4B of capital for on‑lease 737NG/A320ceo (asset‑light for FTAI), Montreal/Miami module throughput ramp with Rome JV to follow, and deleveraging toward ~3.0x by YE25 with potential for buybacks/dividend increases thereafter .
What Went Well and What Went Wrong
-
What Went Well
- Aerospace Products execution: $130.9M Adjusted EBITDA at a 36% margin; management highlighted accelerating demand and a growing 2025+ backlog, with 138 CFM56 modules refurbished across Montreal and Miami in Q1 .
- Strategic Capital Initiative (SCI) on track: 98 aircraft owned/under LOI; SCI designed to reinforce engine exchange flywheel and margin visibility; Q1 had ~30% of activity to SCI; long‑term mix ~20% expected .
- Cash generation/visibility: H1 2025 adjusted FCF guided to $300–$350M; $500M seed asset sale proceeds concentrated in H1; reaffirmed full‑year ~$650M target .
-
What Went Wrong
- Top‑line shortfall vs Street: revenue of $502.1M missed S&P Global consensus of $567.7M (~−11.6%); GAAP diluted EPS was $0.87, while the EPS beat was on normalized basis (Primary EPS) rather than GAAP *. Values with asterisks retrieved from S&P Global.
- Mix/one‑offs in Leasing: Leasing EBITDA included a $30M settlement related to Russian assets written off in 2022, complicating clean run‑rate comparisons; corporate had ~$3M of costs tied to a report this quarter .
- Equity line/elim headwinds: Equity in losses of unconsolidated entities was $(7.6)M (includes ~$7.0M intra‑entity profit eliminations related to SCI), partially offset by $43.9M of other income including gains on sales .
Financial Results
Results vs S&P Global consensus and prior quarter/year:
Values marked with an asterisk (*) are retrieved from S&P Global.
Segment/Revenue composition (Q1 2025):
Key KPIs and operating items:
Guidance Changes
Earnings Call Themes & Trends
Management Commentary
- “We started the year with momentum, recording another strong quarter in aerospace products with $131 million in adjusted EBITDA at a margin of 36%... demand… continues to accelerate.” — CEO Joe Adams .
- “We expect adjusted free cash flow to be in the range of $300 million to $350 million for the first half of the year… in line with our target to achieve $650 million… for all of 2025.” — CEO .
- “Leasing… $162 million of EBITDA… included a $30 million settlement related to Russian assets written off in 2022… We remain comfortable assuming leasing EBITDA will be $500 million in 2025.” — CFO Angela Nam .
- “We do not currently see tariffs having any material negative effect on our business… we have the ability to pass on price increases to customers.” — CEO .
- “We are planning to invest about $200 million in parts in the first half… we’re production‑constrained… better to carry parts than miss a sale.” — CEO .
Q&A Highlights
- SCI mix and cannibalization: ~30% of Q1 activity to SCI (pent‑up), ~20% expected for 2025; management views SCI as additive with no cannibalization and a “virtuous circle” improving visibility and margins .
- Working capital and inventory: ~$200M parts inventory build in H1 to support throughput; intent is to maintain provisioning ahead of shop visits; not seen growing materially quarter‑over‑quarter thereafter .
- PMA trajectory: approvals progressing; airlines increasingly focused on maintenance cost; SCI can accelerate adoption; margin upside not yet fully reflected .
- Lease rates/market strength: no softening; modest increases; narrowbody storage under ~5% supports strong demand and extensions .
- Insurance recoveries: $30M in Q1; ~$24M committed for Q2; ~$100M remaining claims—net recoveries expected to exceed write‑offs .
- Leverage and capital returns: targeting ~3.0x by YE25; after growth CapEx and debt paydown, potential for buybacks/dividend actions toward year‑end .
Estimates Context
- Q1 2025 vs S&P Global consensus: revenue $502.1M vs $567.7M (miss ~11.6%); Primary EPS $1.02 vs $0.95 (beat ~$0.07). GAAP diluted EPS was $0.87. Management cited strong AP margins and SCI progress; Leasing included a $30M settlement, which contributed to EBITDA . Values with asterisks retrieved from S&P Global.
- Q4 2024 vs S&P Global consensus: revenue $498.8M vs $500.9M (slight miss); Primary EPS $0.88 vs $0.89 (in‑line/slight miss) . Values with asterisks retrieved from S&P Global.
- Implications: Street may revise revenue trajectories to reflect mix/timing and intra‑entity eliminations, while maintaining or modestly lifting normalized EPS on AP margin strength and SCI scale; reiterated full‑year segment EBITDA and FCF targets anchor FY25/26 estimates .
Key Takeaways for Investors
- Normalized EPS beat despite revenue miss; AP profitability and margin quality remain the core bull point (AP EBITDA $130.9M at 36% margin) .
- Reiterated FY25 segment EBITDA ($1.10–$1.15B) and FY26 ($~1.4B) with H1 FCF of $300–$350M and full‑year FCF target ~$650M—supports deleveraging to ~3x and potential capital returns late 2025 .
- SCI scaling (> $4B) structurally enhances the engine exchange flywheel and visibility; Q1’s ~30% SCI activity should normalize to ~20% for 2025, with no cannibalization of third‑party demand per management .
- Near‑term working capital heavy (parts inventory front‑loaded in H1), but management prioritizes production and sales capture; inventory growth expected to level as throughput scales .
- Tariff risk appears manageable given used‑material focus, multi‑region footprint, and pricing power; potential long‑term relative tailwind for used assets and PMA adoption .
- Watch Q2 for Montreal module ramp (90–100 modules) and continued SCI asset transitions; monitor insurance recoveries ($24M committed in Q2) as incremental cash tailwinds .
- Trading setup: positive narrative on AP margin durability, capacity ramp, SCI scaling, deleveraging path; temper with revenue estimate reset risk given Q1 miss and mixed one‑offs (settlement gains) .
Values marked with an asterisk (*) are retrieved from S&P Global.
Citations:
- Q1 2025 8‑K/press release and financial statements ; stand‑alone press release .
- Q1 2025 earnings call transcript .
- Q4 2024 press release (prior quarter comps/outlook) .
- Q3 2024 press release (trend) .
- SCI partnership (Mar 25, 2025) .